Philadelphia Positive
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Retrospective Evaluation of CML Patients in the National Compassionate Program (NCT02448095) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2015-12-22 |
| Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia. (NCT01641107) | Incyte Corporation | 2014-12-04 |
Track Philadelphia Positive automatically
Every clearance here is in the API, with alerts when new ones post.